Kuntai Capsules Improve Premature Ovarian Failure by Regulating AMPK-Mediated Autophagy
Reproductive Sciences · 2025-09 · 32 (9) · 2970-2984
DOI: 10.1007/s43032-025-01949-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproductive Sciences, online erschienen am 11.08.2025. Verfasst von Xiaomin Ye und 4 weiteren Autor:innen. Beteiligte Einrichtung: Central People's Hospital of Zhanjiang, Zhanjiang, Guangdong, 524045, China. Hauptthemen laut MEDLINE: Primary Ovarian Insufficiency, Autophagy, Drugs, Chinese Herbal, AMP-Activated Protein Kinases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Premature ovarian failure (POF) is a gynecological endocrine disorder with current treatments having limitations. Kuntai capsule (KTC), a traditional Chinese medicine formulation, is thought to be beneficial for POF, but its mechanism is unclear. Network pharmacology can help explore drug mechanisms.
Methods
A POF rat model was established using cyclophosphamide (CTX). Rats received low-dose KTC (0.6 g/kg/d), high-dose KTC (1.8 g/kg/d), or dehydroepiandrosterone (DHEA, positive control). Ovarian function was evaluated via histopathology, hormone assays (ELISA), apoptosis (TUNEL/flow cytometry), autophagy markers (Western blot), and network pharmacology.
Results
KTC treatment (especially high-dose) ameliorated POF in CTX-treated rats, as shown by increased ovarian weight, restored estrus cycle, and improved follicle development. The serum estradiol (E2), anti-mullerian hormone (AMH), and superoxide dismutase (SOD) levels increased, whereas the follicle-stimulating hormone (FSH), malondialdehyde (MDA), and reactive oxygen species (ROS) levels decreased following KTC treatment. KTC also alleviated ovarian cell apoptosis and autophagy, with higher-dose KTC being more effective. Network pharmacology predicted AMPK/mTOR pathway involvement. Western blot confirmed KTC activated the AMPK/mTOR signaling, downregulated autophagy markers (LC3B-II/I, Beclin1), and upregulated P62. Autophagy inhibition (via 3-MA) mirrored KTC effects, while mTOR blockade (rapamycin) reversed them.
Conclusions
KTC ameliorates POF by inhibiting excessive ovarian autophagy through AMPK/mTOR pathway activation, providing a mechanistic basis for its clinical use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Central People's Hospital of Zhanjiang, Zhanjiang, Guangdong, 524045, China.
- Department of Obstetrics and Reproductive Health and Infertility, Central People's Hospital of Zhanjiang, Zhanjiang, Guangdong, 524045, China. 375382268@qq.com.
ORCID-Profile: Xinmiao Lin
Zitieren
APA
Ye, X., Chen, M., Zhong, J., Chen, H., & Lin, X. (2025). Kuntai Capsules Improve Premature Ovarian Failure by Regulating AMPK-Mediated Autophagy. Reproductive Sciences, 32(9), 2970-2984. https://doi.org/10.1007/s43032-025-01949-w
Vancouver
Ye X, Chen M, Zhong J, Chen H, Lin X. Kuntai Capsules Improve Premature Ovarian Failure by Regulating AMPK-Mediated Autophagy. Reproductive Sciences. 2025;32(9):2970-2984. doi:10.1007/s43032-025-01949-w
BibTeX
@article{Ye2025,
author = {Ye, Xiaomin and Chen, Miao and Zhong, Jiajing and Chen, Haofan and Lin, Xinmiao},
title = {Kuntai Capsules Improve Premature Ovarian Failure by Regulating AMPK-Mediated Autophagy},
journal = {Reproductive Sciences},
year = {2025},
volume = {32},
number = {9},
pages = {2970--2984},
doi = {10.1007/s43032-025-01949-w}
}
EUVIMED